|
|
|
|
|
|
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
Ritanserin in Treatment of Cocaine Dependence
The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
100 项与 DGKA x 5-HT2 receptor 相关的临床结果
100 项与 DGKA x 5-HT2 receptor 相关的转化医学
0 项与 DGKA x 5-HT2 receptor 相关的专利(医药)